Nycomed International Management GmbH · Zurich Switzerland
Company Description
View Nycomed International Management GmbH Locations On A US Map
This link will open in a new window
This link will open in a new window From aching hearts to brittle bones, if you suffer from it, Nycomed probably has a drug for it. The Swiss pharmaceutical company develops presciption and OTC medicines mainly focusing on cardiology, gastroenterology, osteoporosis, respiratory, and pain management therapies. It operates nearly 20 facilities in a dozen European countries, where it conducts its own research and drug testing. It also develops products in conjunction with partner pharmaceutical companies. The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies in Europe, the Americas, Russia, and Asia/Pacific as well as from licensing product rights to and from other companies.. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Nycomed International Management GmbH Financials
| Company Type | Private Headquarters |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $0.6 |
| Employees | 3 |
Nycomed International Management GmbH Executives
20 executives listed for Nycomed International Management GmbH's Zurich, location.
| Title | Name & Bio | Contact |
| Chairman | Toni Weitzberg | Network |
| CEO and Director | Håkan Björklund | Network |
| EVP Operations | Barthold Piening | Network |
Competition
Competitive Landscape for Nycomed International Management GmbH
Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is more than $350,000. Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery. To read the full description, subscribe now.Top Nycomed International Management GmbH Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!